An editorial in response to the editor in chief’s December 2021 letter discusses evidence supporting the cost-effectiveness of an innovative advance care planning initiative.
Isabella Rubin, BA
Advertisement
Articles by Isabella Rubin, BA
Advertisement
Latest Updated Articles
End-of-Life Values and Value-Based CarePublished: May 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
AMCP Nexus Bringing the Latest on Health Policy, Drug Access, and Value-Based Care
4
Prospective Evidence Supports Tumor-First Multigene Testing in Ovarian Cancer
5
